170 related articles for article (PubMed ID: 22232013)
1. Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment.
Mueller C; Schrag M; Crofton A; Stolte J; Muckenthaler MU; Magaki S; Kirsch W
J Alzheimers Dis; 2012; 29(2):341-50. PubMed ID: 22232013
[TBL] [Abstract][Full Text] [Related]
2. Copper subtype of Alzheimer's disease (AD): meta-analyses, genetic studies and predictive value of non-ceruloplasmim copper in mild cognitive impairment conversion to full AD.
Squitti R
J Trace Elem Med Biol; 2014 Oct; 28(4):482-5. PubMed ID: 25066791
[TBL] [Abstract][Full Text] [Related]
3. Homeostasis of metals in the progression of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Biometals; 2014 Jun; 27(3):539-49. PubMed ID: 24668390
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
5. Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
Rozzini L; Lanfranchi F; Pilotto A; Catalani S; Gilberti ME; Paganelli M; Apostoli P; Padovani A
J Alzheimers Dis; 2018; 61(3):907-912. PubMed ID: 29332043
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
Oikonomidi A; Tautvydaitė D; Gholamrezaee MM; Henry H; Bacher M; Popp J
J Alzheimers Dis; 2017; 60(1):273-281. PubMed ID: 28826184
[TBL] [Abstract][Full Text] [Related]
7. Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
Tisato V; Zuliani G; Vigliano M; Longo G; Franchini E; Secchiero P; Zauli G; Paraboschi EM; Vikram Singh A; Serino ML; Ortolani B; Zurlo A; Bosi C; Greco A; Seripa D; Asselta R; Gemmati D
PLoS One; 2018; 13(3):e0193867. PubMed ID: 29518107
[TBL] [Abstract][Full Text] [Related]
8. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
[TBL] [Abstract][Full Text] [Related]
10. B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment.
Jakubowski H; Zioła-Frankowska A; Frankowski M; Perła-Kaján J; Refsum H; de Jager CA; Smith AD
J Alzheimers Dis; 2021; 84(3):1039-1055. PubMed ID: 34602484
[TBL] [Abstract][Full Text] [Related]
11. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
[TBL] [Abstract][Full Text] [Related]
12. Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation.
Crespo ÂC; Silva B; Marques L; Marcelino E; Maruta C; Costa S; Timóteo A; Vilares A; Couto FS; Faustino P; Correia AP; Verdelho A; Porto G; Guerreiro M; Herrero A; Costa C; de Mendonça A; Costa L; Martins M
Neurobiol Aging; 2014 Apr; 35(4):777-85. PubMed ID: 24199959
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.
Tariq S; d'Esterre CD; Sajobi TT; Smith EE; Longman RS; Frayne R; Coutts SB; Forkert ND; Barber PA
BMC Geriatr; 2018 Jul; 18(1):163. PubMed ID: 30012102
[TBL] [Abstract][Full Text] [Related]
14. Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology.
Ashraf A; Ashton NJ; Chatterjee P; Goozee K; Shen K; Fripp J; Ames D; Rowe C; Masters CL; Villemagne V; Hye A; Martins RN; So PW;
Alzheimers Res Ther; 2020 Jun; 12(1):72. PubMed ID: 32517787
[TBL] [Abstract][Full Text] [Related]
15. Effect of cognitive training on the expression of brain-derived neurotrophic factor in lymphocytes of mild cognitive impairment patients.
Casoli T; Giuli C; Balietti M; Giorgetti B; Solazzi M; Fattoretti P
Rejuvenation Res; 2014 Apr; 17(2):235-8. PubMed ID: 24127698
[TBL] [Abstract][Full Text] [Related]
16. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
18. Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.
Gattaz WF; Talib LL; Schaeffer EL; Diniz BS; Forlenza OV
J Neural Transm (Vienna); 2014 Feb; 121(2):193-200. PubMed ID: 24036895
[TBL] [Abstract][Full Text] [Related]
19. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias.
Magaki S; Raghavan R; Mueller C; Oberg KC; Vinters HV; Kirsch WM
Neurosci Lett; 2007 May; 418(1):72-6. PubMed ID: 17408857
[TBL] [Abstract][Full Text] [Related]
20. Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals.
Katsel P; Tan W; Haroutunian V
PLoS One; 2009 Oct; 4(10):e7642. PubMed ID: 19865478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
